MS-DRG |
MS-DRG Description |
014 |
ALLOGENEIC BONE MARROW TRANSPLANT |
016 |
AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC |
017 |
AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC |
018 |
CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY |
054 |
NERVOUS SYSTEM NEOPLASMS WITH MCC |
055 |
NERVOUS SYSTEM NEOPLASMS WITHOUT MCC |
146 |
EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC |
147 |
EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC |
148 |
EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC |
180 |
RESPIRATORY NEOPLASMS WITH MCC |
181 |
RESPIRATORY NEOPLASMS WITH CC |
182 |
RESPIRATORY NEOPLASMS WITHOUT CC/MCC |
374 |
DIGESTIVE MALIGNANCY WITH MCC |
375 |
DIGESTIVE MALIGNANCY WITH CC |
376 |
DIGESTIVE MALIGNANCY WITHOUT CC/MCC |
435 |
MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC |
436 |
MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC |
437 |
MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC |
597 |
MALIGNANT BREAST DISORDERS WITH MCC |
598 |
MALIGNANT BREAST DISORDERS WITH CC |
599 |
MALIGNANT BREAST DISORDERS WITHOUT CC/MCC |
686 |
KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC |
687 |
KIDNEY AND URINARY TRACT NEOPLASMS WITH CC |
688 |
KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC |
722 |
MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC |
723 |
MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC |
724 |
MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
754 |
MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC |
755 |
MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC |
756 |
MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
834 |
ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC |
835 |
ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC |
836 |
ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC |
837 |
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC |
838 |
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT |
839 |
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
840 |
LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC |
841 |
LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC |
842 |
LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC |
843 |
OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC |
844 |
OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC |
845 |
OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC |
846 |
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC |
847 |
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC |
848 |
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
849 |
RADIOTHERAPY |